| Peer-Reviewed

Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction

Received: 31 May 2020     Accepted: 11 June 2020     Published: 23 June 2020
Views:       Downloads:
Abstract

Testing is central, early detection of the virus minimizes its further spread and allows rapid treatment of the sick - said the head of the South Korean Ministry of Foreign Affairs Kang Gyung Hua. He believes effective management and tests are key to our very low mortality rate. South Korea's health and public administration system was able to quickly protect the population from COVID-19 without the imposition of emergency measures. The adviser to the Swedish government and the Secretary-General of the World Health Organization, Yuhan Gizeke, told the RBC in an interview on May 5, 2020 that the authorities of the country relied on two measures in the fight against coronavirus whose benefit has scientific justification. First, we need to wash our hands, which we've known for 150 years. Second, social distance should be respected, that is, not to get too close to other people. Until May 5, 2020, Sweden recorded only 23216 cases of coronavirus infection. Developed countries have begun to develop a vaccine to combat COVID-19. Any vaccine contains a specific antigen - a protein that provokes antibody production - immune response. In the body antigen is met with specially adapted cells - macrophages. They get acquainted with the antigen and read information from it, - explains Alimbarov. - The obtained information they transmit to T lymphocytes, which in turn begin to change, and among them appear cells that will also participate in the immune process. T cells transmit information to B lymphocytes, which are converted into plasma cells capable of producing antibodies. Part of B lymphocytes is converted into memory cells. They store information about the antigen and, upon repeated encounter with a similar antigen, trigger an immune response (antibody formation) in a shorter time frame. The vaccine can be live (weakened virus), inactivated (dead virus) or vector - that's what the coronavirus vaccine will be. It contains a human-harmless adenovirus whose DNA contains the coronavirus gene. The adenovirus is then used as a delivery container.

Published in American Journal of Management Science and Engineering (Volume 5, Issue 2)
DOI 10.11648/j.ajmse.20200502.11
Page(s) 19-23
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Covid-19, To Work Quickly, To Do Many Tests, Biogenic Health Maintenance in Ontogenesis

References
[1] E. G. Bryndin, I. E. Bryndina. Sanatorium Rehabilitation of the Population by the Healthy Lifestyle. International journal “Rehabilitation Sciences”, Volume 2, Issue 2. USA. 2017. P. 35-40.
[2] Bryndin E. G., Bryndina I. E. Normalization of Psyche by Healthy Lifestyle of Various Groups of the Population. American Journal of Applied Psychology. V. 6, № 4. 2017, Pages: 51-56.
[3] E. G. Bryndin, I. E. Bryndina. Formation of Public Health Care on Basis of Healthy Lifestyle. International Journal of Psychological and Brain Sciences. Vol. 2, No. 3, 2017, pp. 63-68.
[4] Bryndin E. G., Bryndina I. E. Natural Measures of Normalization of Vital Systems of the Person for Maintaining of the Healthy State. International Physical Medicine & Rehabilitation Journal. V. 3 Issue 1. 2018. 8 pages. URL: http://medcraveonline.com/IPMRJ/IPMRJ-03-00069.php
[5] Bryndin E. G. Healthy lifestyle basis of maintaining health. Germany: LAMBERT Academic Publishing. 2018. 230 с.
[6] Evgeniy Bryndin. Development of living floor spaces on the basis of ecological economic and social programs. J. Resources and Environmental Economics. V. 1, N. 1.2018. P. 1-8.
[7] Bryndin E. G., Bryndina I. E. Hygiene and Endoecology, Light Bioenergy and Natural Ecology, Balanced Mentality and Spiritual Life as Criterion of Health. Innovative Journal of Medical and Health Science. Vol 9, Iss 2, 299–306. 2019.
[8] Evgeniy Bryndin, Irina Bryndina. Natural Science Approach to Determination of Health and Formation of Healthy Lifestyle. ACTA SCIENTIFIC MEDICAL SCIENCES JOURNAL. Vol. 3, Issue 1. 2019. P. 26-37.
[9] Evgeniy Bryndin, Irina Bryndina. Development of Health Care on Basis of Healthy Lifestyle for Forming Future Medicine of Longevity. Acta Scientific Medical Sciences 3.5 (2019): 35-41.
[10] Evgeniy Bryndin, Irina Bryndina. International Public Health Care on Basis Healthy Lifestyle. Asian Journal of Medical Science Research & Review, Volume 1, Issue 2. 2019. Pages: 88-96.
[11] Bryndin E, Bryndina I. Training of Healthy Lifestyle in Educational Schools. Asclepius Medical Case Reports 2019; 2 (1): 1-3.
[12] Bryndin E. G., Bryndina I. E. Health Maintenance by Balanced Psyche, Spiritual Life, Hygiene, Endoecology and Ecological Nature. Research and Reviews on Healthcare: Open Access Journal, V. 4, № 1. 2019. Pages 322-328.
[13] Bryndin E. G. Bryndina I. E., Putmakov A. N. Enhanced action of the Person by Healthy Lifestyle and Correction of the Biofield by the Tomography Method. Journal of Medical Review. ISSN (Online): 2589-9074, ISSN (Print): 2589-9066. 2019. Pages: 286-292.
[14] Evgeniy Bryndin, Irina Bryndina. Supporting Technology of Vigorous Activity by Normalization of Biofield and by Healthy Lifestyle. Journal of Integral Sciences, 2019, Vol. 2, Issue 2. Pages: 1-9.
[15] Evgeniy Bryndin, Irina Bryndina. Normalization of Psyche of the Motivated Population by Healthy Lifestyle. Lupine Online Journal Medical Sciences 4 (2) - 2019. Pages: 364-367.
[16] Evgeniy Bryndin. Self Healing of Healthy Condition at Cellular Level. Medical Case Reports and Reviews, Volume 3, London. 2020. Pages: 1-4.
[17] Bible. GmbH West Germany: Christlicher Verlag. 1991. 1210 pages.
Cite This Article
  • APA Style

    Evgeniy Bryndin, Irina Bryndina. (2020). Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction. American Journal of Management Science and Engineering, 5(2), 19-23. https://doi.org/10.11648/j.ajmse.20200502.11

    Copy | Download

    ACS Style

    Evgeniy Bryndin; Irina Bryndina. Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction. Am. J. Manag. Sci. Eng. 2020, 5(2), 19-23. doi: 10.11648/j.ajmse.20200502.11

    Copy | Download

    AMA Style

    Evgeniy Bryndin, Irina Bryndina. Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction. Am J Manag Sci Eng. 2020;5(2):19-23. doi: 10.11648/j.ajmse.20200502.11

    Copy | Download

  • @article{10.11648/j.ajmse.20200502.11,
      author = {Evgeniy Bryndin and Irina Bryndina},
      title = {Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction},
      journal = {American Journal of Management Science and Engineering},
      volume = {5},
      number = {2},
      pages = {19-23},
      doi = {10.11648/j.ajmse.20200502.11},
      url = {https://doi.org/10.11648/j.ajmse.20200502.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajmse.20200502.11},
      abstract = {Testing is central, early detection of the virus minimizes its further spread and allows rapid treatment of the sick - said the head of the South Korean Ministry of Foreign Affairs Kang Gyung Hua. He believes effective management and tests are key to our very low mortality rate. South Korea's health and public administration system was able to quickly protect the population from COVID-19 without the imposition of emergency measures. The adviser to the Swedish government and the Secretary-General of the World Health Organization, Yuhan Gizeke, told the RBC in an interview on May 5, 2020 that the authorities of the country relied on two measures in the fight against coronavirus whose benefit has scientific justification. First, we need to wash our hands, which we've known for 150 years. Second, social distance should be respected, that is, not to get too close to other people. Until May 5, 2020, Sweden recorded only 23216 cases of coronavirus infection. Developed countries have begun to develop a vaccine to combat COVID-19. Any vaccine contains a specific antigen - a protein that provokes antibody production - immune response. In the body antigen is met with specially adapted cells - macrophages. They get acquainted with the antigen and read information from it, - explains Alimbarov. - The obtained information they transmit to T lymphocytes, which in turn begin to change, and among them appear cells that will also participate in the immune process. T cells transmit information to B lymphocytes, which are converted into plasma cells capable of producing antibodies. Part of B lymphocytes is converted into memory cells. They store information about the antigen and, upon repeated encounter with a similar antigen, trigger an immune response (antibody formation) in a shorter time frame. The vaccine can be live (weakened virus), inactivated (dead virus) or vector - that's what the coronavirus vaccine will be. It contains a human-harmless adenovirus whose DNA contains the coronavirus gene. The adenovirus is then used as a delivery container.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction
    AU  - Evgeniy Bryndin
    AU  - Irina Bryndina
    Y1  - 2020/06/23
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ajmse.20200502.11
    DO  - 10.11648/j.ajmse.20200502.11
    T2  - American Journal of Management Science and Engineering
    JF  - American Journal of Management Science and Engineering
    JO  - American Journal of Management Science and Engineering
    SP  - 19
    EP  - 23
    PB  - Science Publishing Group
    SN  - 2575-1379
    UR  - https://doi.org/10.11648/j.ajmse.20200502.11
    AB  - Testing is central, early detection of the virus minimizes its further spread and allows rapid treatment of the sick - said the head of the South Korean Ministry of Foreign Affairs Kang Gyung Hua. He believes effective management and tests are key to our very low mortality rate. South Korea's health and public administration system was able to quickly protect the population from COVID-19 without the imposition of emergency measures. The adviser to the Swedish government and the Secretary-General of the World Health Organization, Yuhan Gizeke, told the RBC in an interview on May 5, 2020 that the authorities of the country relied on two measures in the fight against coronavirus whose benefit has scientific justification. First, we need to wash our hands, which we've known for 150 years. Second, social distance should be respected, that is, not to get too close to other people. Until May 5, 2020, Sweden recorded only 23216 cases of coronavirus infection. Developed countries have begun to develop a vaccine to combat COVID-19. Any vaccine contains a specific antigen - a protein that provokes antibody production - immune response. In the body antigen is met with specially adapted cells - macrophages. They get acquainted with the antigen and read information from it, - explains Alimbarov. - The obtained information they transmit to T lymphocytes, which in turn begin to change, and among them appear cells that will also participate in the immune process. T cells transmit information to B lymphocytes, which are converted into plasma cells capable of producing antibodies. Part of B lymphocytes is converted into memory cells. They store information about the antigen and, upon repeated encounter with a similar antigen, trigger an immune response (antibody formation) in a shorter time frame. The vaccine can be live (weakened virus), inactivated (dead virus) or vector - that's what the coronavirus vaccine will be. It contains a human-harmless adenovirus whose DNA contains the coronavirus gene. The adenovirus is then used as a delivery container.
    VL  - 5
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Research Centre "Nature Informatic" of Technological Platform Future Medicine, Novosibirsk, Russia

  • Pediatric Faculty of Novosibirsk State Medical University, Novosibirsk, Russia

  • Sections